News Announcement

Solara Active Pharma Sciences: Announcement under Regulation 30 (LODR)-Change in Directorate

We wish to inform you that the Board of Directors at its meeting held today appointed Mr. Ronald Tjeerd De Vries as Additional Director and Independent Director of the Company for a period of five years with effect from October 30, 2018

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.